Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Viome Launches the First Personalized AM/PM Toothpaste & Gel Formulated Using Oral Microbiome Data and AI to Support Whole-body Health


News provided by

Viome

Jul 17, 2024, 09:00 ET

Share this article

Share toX

Share this article

Share toX

This groundbreaking product fulfills an unmet oral health market need, surpassing traditional toothpaste's benefits and focusing on underlying causes of poor oral health and other chronic health conditions.

BELLEVUE, Wash., July 17, 2024 /PRNewswire/ -- Viome, a leading provider of personalized microbiome health products and solutions, today unveiled its pioneering VRx MyBiotics Toothpaste & Gel to complete its Oral Health Solution system, setting a new standard for daily oral care and support overall health. This innovative product utilizes the unprecedented oral health insights from the Oral Health Intelligence™ Test (also available with Full Body Intelligence™) to create a personalized toothpaste formula that addresses each individual's specific oral health needs and nutrition for full body health. Acting as a dual-action deep cleanser and supplement, the MyBiotics Toothpaste & Gel features safe-to-ingest ingredients that effectively clean the mouth, care for gums, strengthen teeth, and benefit the entire body.

Continue Reading
The MyBiotics Toothpaste & Gel breaks brushing down to a science.
The MyBiotics Toothpaste & Gel breaks brushing down to a science.

With tooth decay affecting 90 percent of US adults and gum disease impacting 50 percent of US adults, it is clear that traditional toothpastes aren't working. The oral microbiome, a complex community of microorganisms in the mouth, is crucial in maintaining oral and overall health. Oral health issues caused by underlying, suboptimal microbial activities – such as cavities, gum disease, and tooth loss – can and do affect overall health. As the entry point to your entire body, the oral microbiome has been implicated in many systemic diseases. In fact, 95 percent of Americans with diabetes also experience periodontal disease, and up to 50 percent of heart attacks and strokes are attributed to oral pathogens. Additionally, those affected by gum disease are 70 percent more likely to develop Alzheimer's.

Viome has historically been a pioneer in personalized health, starting with its early adoption of the gut microbiome, its impact on overall systemic health, and its role in the progression of chronic conditions and aging. In the last few years, the company has uncovered the essential role of the oral microbiome and its equally crucial impact on health. Viome is leading the way for a new frontier of personalized and preventative oral health, committed to increasing access to products that address underlying root causes. Viome's oral health products are designed to boost the mouth's defense mechanisms naturally and effectively, leading to cleaner teeth, healthier gums, and a stronger microbial community that supports full-body defenses.

"At Viome, we are committed to revolutionizing the oral health landscape with the same focus on individualization and prevention, harnessing the power of our unique technology to provide custom solutions that make daily habits more effective and meaningful. Our new MyBiotics Toothpaste & Gel product exemplifies our mission to continue providing these solutions as we better understand the human microbiome and its role in health and aging," said Viome founder & CEO Naveen Jain. "As we grow, we remain dedicated to transforming our data and discoveries into actionable products that reshape health and wellness, one microbiome at a time."

The MyBiotics Toothpaste & Gel breaks brushing down to a science. Viome's at-home test analyzes the saliva of each individual, measuring the unique activity of their oral microbes and determining how they may be contributing to bad breath, gum inflammation, cavities, and other common oral health concerns. Viome maps each user's activity from there to specific prebiotics, postbiotics, polyphenols, and other effective ingredients. The MyBiotics Toothpaste & Gel formula is meant to work synergistically, from morning through night, to support oral microbes and keep the mouth healthy and resilient. It is free of harsh abrasives, sugar, dioxides, SLS, saccharin, triclosan, sulfates, BPA, phthalates, parabens, and artificial sweeteners or colors.

  • Sunrise Cleanse & Restore Gel (AM Pack) - Start with the MyBiotics Gel for a deeper clean. Powered by Livfresh Technology and formulated from 26 research studies at top US universities, it works up to 250 percent better at removing plaque than leading toothpaste brands, 250 percent better at reducing gum puffiness, twice as effective at controlling overnight plaque buildup, and shields your teeth from plaque-forming microbes and tooth staining. By using a synergistic blend of Methylsulfonylmethane (MSM) and Sodium Tripolyphosphate (STPP), Viome's Gel not only removes existing plaque but also forms a protective barrier that repels bacteria and prevents new plaque from attaching to your teeth.
  • Nightly Nourish & Protect Toothpaste (PM Pack) - The MyBiotics Toothpaste formula is an oral supplement that contains both oral and full-body health benefits when ingested. It includes each user's personalized formula, complete with prebiotics, postbiotics, and other powerful, evidence-based ingredients designed to address their test's Oral Health Scores. This formula also supports the natural repair process of the teeth through remineralization for more resilient teeth over time. Employing safe, enamel-friendly molecules to effectively whiten teeth without the harsh abrasives commonly found in other whitening products ensures a brighter smile while preserving the natural integrity of enamel.

"Leveraging the latest breakthroughs in oral health science, Viome's products are designed to outperform leading toothpaste brands by transforming your oral microbes into beneficial allies for your overall health," said Viome's Chief Dental Officer, Edward Zuckerberg. "These benefits are crucial because they improve oral hygiene and enhance overall health by reducing the risk of systemic diseases linked to oral health issues. After decades of stagnation in the oral care industry, Viome is introducing the innovation consumers have been waiting for, revolutionizing daily oral care with scientifically advanced solutions promoting a healthier mouth and body."

This latest announcement comes off the heels of multiple different initiatives Viome has spearheaded to improve our approach to oral care, including the debut of their first B2B product, Oral Health Pro™ with CancerDetect®, and a corresponding partnership with medical device distributor Henry Schein to provide better access to the test. For more information, please visit https://www.viome.com/.

About Viome
Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Utilizing cutting-edge AI and the world's largest gene expression database, Viome's home-based tests offer individuals personalized nutritional guidance and innovative microbiome health products to enhance lifespan and health.

Viome has empowered over half a million users with its unique approach that marries groundbreaking proprietary RNA sequencing methods with AI technology. This combination analyzes epigenetic biomarkers, providing robust, AI-driven health insights that contribute significantly to promoting a healthy lifespan. With its top-tier precision nutrition recommendations, Viome offers a comprehensive and personalized solution to aging - at its optimum. This is more than just health optimization; it's a revolution in understanding how we age and enabling us to do so with vitality and wellness.

SOURCE Viome

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.